Skopos Labs, Inc. Embecta Corp. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Skopos Labs, Inc. holds 3,590 shares of EMBC stock, worth $38,089. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,590
Previous 284
1164.08%
Holding current value
$38,089
Previous $5,000
800.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EMBC
# of Institutions
415Shares Held
56.3MCall Options Held
54.8KPut Options Held
32.3K-
Black Rock Inc. New York, NY9.19MShares$97.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$71.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.81MShares$40.5 Million0.03% of portfolio
-
River Road Asset Management, LLC3.23MShares$34.2 Million0.58% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.72MShares$28.9 Million0.88% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $614M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...